The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of serial 18F-Fluorothymidine (FLT) PET and Ki-67 to predict response to aromatase inhibitors (AI) in women with ER+ breast cancer.
 
Toni Kay Roberts
No Relationships to Disclose
 
Lanell Peterson
No Relationships to Disclose
 
Brenda Kurland
Research Funding - Merck (Inst)
 
Alena Novakova
No Relationships to Disclose
 
Andrew Shields
No Relationships to Disclose
 
Robert K Doot
No Relationships to Disclose
 
Erin K Schubert
No Relationships to Disclose
 
Vijayakrishna K. Gadi
No Relationships to Disclose
 
Jennifer M. Specht
Research Funding - Abbvie (Inst); Celgene (Inst); Celldex (Inst); Genentech/Roche (Inst); Merck (Inst); Nektar (Inst); Pfizer (Inst); Seagen (Inst)
 
Julie Gralow
Consulting or Advisory Role - Bayer; Genentech; Lilly; Novartis
Research Funding - Amgen (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Janet F. Eary
No Relationships to Disclose
 
Mark Muzi
No Relationships to Disclose
 
Jeanne Link
No Relationships to Disclose
 
Kenneth A. Krohn
No Relationships to Disclose
 
David A. Mankoff
No Relationships to Disclose
 
Hannah M. Linden
No Relationships to Disclose